Ignyte Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IGNY and buy or sell other stocks, ETFs, and their options commission-free!About IGNY
Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease.
CEOStephen J. LaMond, PhD, MBA
CEOStephen J. LaMond, PhD, MBA
Employees—
Employees—
HeadquartersPleasanton, California
HeadquartersPleasanton, California
Founded2016
Founded2016
Employees—
Employees—
IGNY Key Statistics
Market cap520.31K
Market cap520.31K
Price-Earnings ratio-0.14
Price-Earnings ratio-0.14
Dividend yield—
Dividend yield—
Average volume6.61K
Average volume6.61K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.2646
52 Week high$0.2646
52 Week low$0.002
52 Week low$0.002
Stock Snapshot
With a market cap of 520.31K, Ignyte Acquisition(IGNY) trades at $0.02. The stock has a price-to-earnings ratio of -0.14.
During the trading day, Ignyte Acquisition(IGNY) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 6.61K.
The stock's 52-week range extends from a low of $0.00 to a high of $0.26.
The stock's 52-week range extends from a low of $0.00 to a high of $0.26.
People also own
Based on the portfolios of people who own IGNY. This list is generated using Robinhood data, and it’s not a recommendation.